Abstract
Multidrug-resistant tuberculosis (MDR-TB) is defined by bacillary resistant to at least isoniazid and rifampicin in vitro. Although a great diversity of reasons accounting for MDR-TB, poor treatment adherence of patient or inappropriate prescription of physicians are still the major causes. Implementation of DOTS (directly observed therapy, short-course) could decrease incidence of MDR-TB. For MDR-TB, prevention is best strategy. Besides, implantation of DOTS-plus also could increase cure rate. To build efficacious framework system for managing tuberculosis is an important issue to prevent and treat MDR-TB.
| Translated title of the contribution | Multidrug-Resistant Tuberculosis |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 524-531 |
| Number of pages | 8 |
| Journal | Journal of Internal Medicine of Taiwan |
| Volume | 20 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2009 |
Keywords
- 多重抗藥性結核病
- 都治計畫
- 進階都治計劃
- Multidrug-resistant tuberculosis
- Directly observed therapy, short-course
- DOTS
- DOTS-Plus
